Clinical Trial Update: Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease [Phase 1]

View source ↗

Summary

Phase 1 study of S-4321 in autoimmune and immune-mediated diseases; the trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Cutaneous Lupus Erythematosus
• Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• S-4321

Snippet

Sponsor: Seismic Therapeutic AU Pty Ltd | Conditions: Autoimmune Diseases, Rheumatoid Arthritis (RA) | Phase 1 | Status: NOT_YET_RECRUITING